Pawan Rao MD, FASN🩺
@nephronus
Followers
1K
Following
487
Media
130
Statuses
2K
❤️ preserving, treating & transplanting kidneys. Chief @stjosephshealth. @UTHealthSA alum. #NephSap reviewer. #Cricket enthusiast. @cuse fan! Love #nephtwitter
Syracuse, NY
Joined April 2010
En hemodiálisis, el 46% tiene hiperkalemia recurrente; cuando los valores de potasio son >6.0 mmol/L, se asoció a ↑2 veces el riesgo de todas las causas de muerte y de presentar evento cardiovascular BMC Nephrology 2025 https://t.co/r2lG7GJYYt
0
10
24
🚨 NEFROLOGÍA: ¡La restricción de sodio en la dieta 🧂 se asocia con un menor riesgo de hiperfiltración en ERC etapa 3! Un hallazgo crucial para preservar la TFG y el control de la HTA. Menos sodio = Más protección renal. Fuente: https://t.co/thZ1qDNXD0
#ERC #Nefrología
ajkd.org
An estimated 8% to 16% of the world’s population has chronic kidney disease, defined by low glomerular filtration rate or albuminuria. Progression of chronic kidney disease is associated with adverse...
0
11
41
Immune checkpoint inhibitor–associated nephritis: treatment standard 🆓 access: https://t.co/rKsGiIOmbV
0
18
51
“A Change is Gonna Come” to Treatment of Lupus Nephritis: A Review @TWhittier_RUSH
https://t.co/3aCXnJfnIj
1
26
71
0
15
34
🧵 Hilo: Complicaciones del Acceso Vascular en Hemodiálisis — Lo que TODO nefrólogo debe dominar Basado en JAMA Surgery 2025. @bernardo_moguel @ArgaizR @IntervenNephMx @sengndi @nefrointerpocus @ASDINNews @ISNkidneycare
1
29
85
There's a big shift in cardiology to the high-risk, non-obstructed, inflamed artery and reducing heart attacks https://t.co/foSaaTYUD4
16
100
467
IgG4-Related disease: From diagnosis to remission https://t.co/lXo4MMl4vi Immunoglobulin G4-related disease (IgG4-RD) is a systemic fibroinflammatory disorder that can affect many organ systems. This article provides a comprehensive overview of current knowledge regarding IgG4-RD
0
9
16
3
100
333
Review by Anthony Bleyer et al: Autosomal Dominant Tubulointerstitial Kidney Disease: A Review https://t.co/ZmGIQafBMb (FREE)
1
46
103
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study - The Lancet
thelancet.com
Pemvidutide treatment met the primary endpoint of MASH resolution without worsening of fibrosis at 24 weeks but did not meet the other primary endpoint of fibrosis improvement without worsening of...
2
13
33
Stopping Blood Thinners Before Surgery? Most people STILL get it wrong. Here’s the cleanest peri-op cheat-sheet you’ll read today 👇 1️⃣ VKA (Warfarin / Acenocoumarol) • Stop 5 days before • Bridge only if very high thrombotic risk • Restart: Day +1 (low-bleed) or Day +2
Pre-surgery blood thinner cheat sheet (made simple): •Warfarin → Stop 3–5 days before; bridge if needed; restart 24–72 h after •DOACs (Apixaban/Rivaroxaban/Dabigatran) → Stop 1–2 days before (earlier if renal disease); restart 24–48 h after •Aspirin → Usually continued
5
84
300
🚨 If your “CIDP” patient isn’t improving… stop. It might be POEMS. Painful neuropathy + λ M-protein = don’t ignore it. Sclerotic bone lesions stay silent. VEGF doesn’t. Miss it → irreversible nerve loss. Catch it → curable plasma-cell disease. #MedTwitter #Neurology
4/ 💧 Sjögren’s Disease : •High risk of lymphoma (mostly MALT) •Hypergammaglobulinemia, monoclonal proteins •Vasculitis with purpura (esp with anti-Ro/La)
3
27
113
So much of my learning and growth as a trainee came from bedside rounds during residency. This is so worth the read.
nejm.org
Bedside clinical skills have been diminished by an overreliance on technology. This article presents educational strategies for reinvigorating the bedside encounter and shows how much can be learne...
2
3
33
Obesity Rate Declining in U.S. Use of GLP-1 injectables for weight loss has more than doubled since early 2024 | @Gallup
https://t.co/0mut7i0VhX
3
3
14
🎯Review @TheLancet The future of type 1 diabetes therapy. "New breakthroughs offer renewed hope for improving long-term management and quality of life for people living with type 1 diabetes." https://t.co/BzqIlCzuC0
3
46
161